Eric S Christenson

8PUBLICATIONS
38CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 02, 2025
Oncolytic peptide NF27 effectively inhibits tumor growth and eradicates tumors in multiple cancer types.

Natsuki Furukawa, Alex R Chao, Wendy Yang

|May 19, 2025
Nivolumab and Relatlimab for the Treatment of Patients with Unresectable or Metastatic Mismatch Repair-Proficient Colorectal Cancer.

Eric S Christenson, Won Jin Ho, Daniel Shu

|Jan 20, 2025
The impact of KRAS mutations on the clinical outcome and immune response following immunotherapy for pancreatic cancer.

Eric S Christenson, Raymond Yu, Jessica Gai

|Jan 05, 2024
Circulating Tumor DNA to Predict Radiographic and Pathologic Response to Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer.

Stephanie L Alden, Valerie Lee, Amol K Narang

|Mar 27, 2023
Cell-free DNA Predicts Prolonged Response to Multi-agent Chemotherapy in Pancreatic Ductal Adenocarcinoma.

Eric S Christenson, Su Jin Lim, Jennifer Durham

|Jul 05, 2022
Is PD-1 Inhibitor Monotherapy a New Standard Treatment for MMR-Deficient Locally Advanced Rectal Cancer?

Eric S Christenson, Jeffrey Meyer

Pageof 2

Frequent Collaborators

2 joint publications

Jennifer N Durham

2 joint publications

Ana De Jesus-Acosta

2 joint publications

Katherine M Bever

2 joint publications

Daniel Laheru